LEBLANC; Heidi N.

Patent Applications and Registrations

Patent applications and USPTO patent grants for LEBLANC; Heidi N..The latest application filed is for "human antibodies that bind lymphocyte activation gene-3 (lag-3), and uses thereof".

Company Profile

5.21.29

LEBLANC; Heidi N. - Mountain View CA
Leblanc; Heidi N. - Milpitas CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Human Antibodies that Bind Lymphocyte Activation Gene-3 (LAG-3), and Uses Thereof App 20220204612 - THUDIUM; Kent B. ; et al.	2022-06-30
Human Antibodies that Bind Lymphocyte Activation Gene-3 (LAG-3), and Uses Thereof App 20220195040 - THUDIUM; Kent B. ; et al.	2022-06-23
Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof Grant 11,236,163 - Thudium , et al. February 1, 2	2022-02-01
Human antibodies that bind Lymphocyte Activation Gene-3 (LAG-3), and uses thereof Grant 11,236,165 - Thudium , et al. February 1, 2	2022-02-01
Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof Grant 11,236,164 - Thudium , et al. February 1, 2	2022-02-01
Binding Molecules To The Human Ox40 Receptor App 20220002428 - MIN; Jing ; et al.	2022-01-06
Human Antibodies that Bind Lymphocyte Activation Gene-3 (LAG-3), and Uses Thereof App 20210261661 - THUDIUM; Kent B. ; et al.	2021-08-26
Human Antibodies that Bind Lymphocyte Activation Gene-3 (LAG-3), and Uses Thereof App 20210261660 - THUDIUM; Kent B. ; et al.	2021-08-26
Human Antibodies that Bind Lymphocyte Activation Gene-3 (LAG-3), and Uses Thereof App 20210261662 - THUDIUM; Kent B. ; et al.	2021-08-26
Human antibodies that bind lymphocyte activation Gene-3 (LAG-3), and uses thereof Grant 11,001,630 - Thudium , et al. May 11, 2	2021-05-11
Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof Grant 10,988,536 - Thudium , et al. April 27, 2	2021-04-27
Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof Grant 10,988,535 - Thudium , et al. April 27, 2	2021-04-27
Human Antibodies that Bind Lymphocyte Activation Gene-3 (LAG-3), and Uses Thereof App 20200385466 - THUDIUM; Kent B. ; et al.	2020-12-10
Human Antibodies that Bind Lymphocyte Activation Gene-3 (LAG-3), and Uses Thereof App 20200385467 - THUDIUM; Kent B. ; et al.	2020-12-10
Human Antibodies That Bind Lymphocyte Activation Gene-3 (lag-3), And Uses Thereof App 20200231671 - THUDIUM; Kent B. ; et al.	2020-07-23
Human Antibodies That Bind Lymphocyte Activation Gene-3 (lag-3), And Uses Thereof App 20190276538 - Thudium; Kent B. ; et al.	2019-09-12
Human Antibodies That Bind Lymphocyte Activation Gene-3 (lag-3), And Uses Thereof App 20190276539 - Thudium; Kent B. ; et al.	2019-09-12
Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof Grant 10,344,089 - Thudium , et al. July 9, 2	2019-07-09
Binding Molecules To The Human Ox40 Receptor App 20190135932 - MIN; Jing ; et al.	2019-05-09
Fully Human Antibodies To Btla App 20190119381 - MATARAZA; Jennifer Marie ; et al.	2019-04-25
Binding molecules to the human OX40 receptor Grant 10,196,452 - Min , et al. Fe	2019-02-05
Fully human antibodies to BTLA Grant 10,155,813 - Mataraza , et al. Dec	2018-12-18
Human Antibodies That Bind Lymphocyte Activation Gene-3 (lag-3), And Uses Thereof App 20180066054 - THUDIUM; Kent B. ; et al.	2018-03-08
Binding Molecules To The Human Ox40 Receptor App 20180057600 - MIN; Jing ; et al.	2018-03-01
Binding molecules to the human OX40 receptor Grant 9,840,562 - Min , et al. December 12, 2	2017-12-12
Human Antibodies That Bind Cd22 And Uses Thereof App 20170058031 - King; David John ; et al.	2017-03-02
Human antibodies that bind CD22 and uses thereof Grant 9,499,632 - King , et al. November 22, 2	2016-11-22
Fully Human Antibodies To Btla App 20160222114 - MATARAZA; Jennifer Marie ; et al.	2016-08-04
Fully human antibodies to BTLA Grant 9,346,882 - Mataraza , et al. May 24, 2	2016-05-24
Monoclonal antibodies against Glypican-3 Grant 9,217,033 - Terrett , et al. December 22, 2	2015-12-22
Binding Molecules To The Human Ox40 Receptor App 20150218279 - Min; Jing ; et al.	2015-08-06
Binding molecules to the human OX40 receptor Grant 9,028,824 - Min , et al. May 12, 2	2015-05-12
Monoclonal Antibodies Against Glypican-3 App 20140186892 - Terrett; Jonathan Alexander ; et al.	2014-07-03
Fully Human Antibodies To Btla App 20140017255 - MATARAZA; Jennifer Marie ; et al.	2014-01-16
Fully human antibodies to BTLA Grant 8,563,694 - Mataraza , et al. October 22, 2	2013-10-22
Human Antibodies That Bind Cd22 And Uses Thereof App 20130230530 - King; David John ; et al.	2013-09-05
Human antibodies that bind CD22 and uses thereof Grant 8,481,683 - King , et al. July 9, 2	2013-07-09
Fully Human Antibodies Specific To Cadm1 App 20130156788 - TERRETT; Jonathan Alexander ; et al.	2013-06-20
Binding Molecules To The Human Ox40 Receptor App 20120225086 - Min; Jing ; et al.	2012-09-06
Binding molecules to the human OX40 receptor Grant 8,236,930 - Min , et al. August 7, 2	2012-08-07
Fully Human Antibodies To Btla App 20120183565 - Mataraza; Jennifer Marie ; et al.	2012-07-19
Binding Molecules To The Human Ox40 Receptor App 20110206681 - Min; Jing ; et al.	2011-08-25
Antibodies To Bone Morphogenic Proteins And Receptors Therefor And Methods For Their Use App 20110182904 - Zimmerman; Deborah ; et al.	2011-07-28
Human Antibodies That Bind Lymphocyte Activation Gene-3 (lag-3) And Uses Thereof App 20110150892 - Thudium; Kent B. ; et al.	2011-06-23
Binding molecules to the human OX40 receptor Grant 7,960,515 - Min , et al. June 14, 2	2011-06-14
Human Antibodies That Bind Cd22 And Uses Thereof App 20100143368 - King; David John ; et al.	2010-06-10
Binding Molecules To The Human Ox40 Receptor App 20090214560 - Min; Jing ; et al.	2009-08-27